Development, implementation and evaluation of Educational tools and Decision Aids for immune checkpoint-inhibitors in advanced LUng cancer: a mixed-methods Study (DEDALUS) / Part I: Development

Development, implementation and evaluation of Educational tools and Decision Aids for immune checkpoint-inhibitors in advanced LUng cancer: a mixed-methods Study (DEDALUS) / Part I: Development - DEDALUS I

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032683

Enrollment

Registered

2023-09-14

Start date

2023-10-02

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34.9

Interventions

Group 1: Patients with advanced lung cancer eligible for or during immunotherapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Stage IV lung cancer, before, under or after immunotherapy (immune checkpoint inhibitors)

Exclusion criteria

Exclusion criteria: inadequate knowledge of German, incapable of giving informed consent

Design outcomes

Primary

Measure	Time frame
Exploration of information needs and preferences, disease and treatment understanding, prognostic awareness, knowledge transfer, influence of personal values and emotions, interaction with health professionals.	—

Secondary

Measure	Time frame
Experiences of illness (causes, timeline, control, consequences, coherence, and/or emotional representations), the attitude towards involvement, the interactions, expectations, and relationships with health professionals and involved other persons, decision self-efficacy, decision conflicts, trust, sense of autonomy, coping strategies, barriers for implementation of shared decision making.	—

Countries

Germany

Contacts

Public ContactMatthias Villalobos

Universitätsklinikum Heidelberg Thoraxklinik Heidelberg

matthias.villalobos@med.uni-heidelberg.de062213968042

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026